Fresenius Medical Care AG & Co. KGaA operates within the Kidney dialysis centers sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Fresenius Medical Care AG & Co. KGaA with three other
health care providers in Europe:
Orpea SA
of France
(2017
sales of 3.14 billion Euro [US$3.55 billion]
),
Ramsay Generale De Sante SA
of France
(2.23 billion Euro [US$2.53 billion]
of which 82%
was Hospitals/Surgery), and
Fresenius SE & Co KGaA
(33.89 billion Euro [US$38.33 billion]
of which 52%
was Fresenius Medical Care).
Sales Analysis.
During the year ended December of 2017, sales at
Fresenius Medical Care AG & Co. KGaA were 17.78 billion Euro (US$20.12 billion).
This
is
an
increase of 9.6%
versus 2016, when the company's sales were 16.23 billion Euro.
This was the fifth consecutive year of sales increases at Fresenius Medical Care AG & Co. KGaA
(and since 2012, sales have increased a total of 66%).
Sales of Corporate / Eliminations saw an increase
of
13.1% in 2017, from
13.04 million Euro to 14.75 million Euro.